Bladder Neoplasm
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
SOD2 and GPX1 expression and GPX1 and SOD1 activity were significantly higher in patients at diagnosis of BC in comparison to controls.
|
28179340 |
2017 |
Bladder Neoplasm
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The present case-control study was planned to assess the presence of GPX1 Pro198Leu polymorphism in Moroccan population to determine whether it is associated with the risk of developing bladder cancer in Moroccan patients.
|
28145855 |
2016 |
Bladder Neoplasm
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
By pooling all eligible studies, we found that the GPX1 Pro198Leu polymorphism was associated with a significantly increased risk of bladder cancer (Leu vs.
|
24037914 |
2014 |
Bladder Neoplasm
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
This meta-analysis was designed to determine the exact association of GPX1 rs1050450 C > T polymorphism with the risk of bladder cancer and prostate cancer.
|
23975365 |
2014 |
Bladder Neoplasm
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Additionally, patients carrying both Ala/Ala of MnSOD and Leu/Leu of GPX1 had the highest risk of developing bladder cancer.
|
21904836 |
2012 |
Bladder Neoplasm
|
0.400 |
Biomarker
|
disease |
BEFREE |
Our data indicate that common genetic variations in GSTM1, GSTT1, and GPX1 were not associated with bladder cancer risk.
|
21586620 |
2011 |
Bladder Neoplasm
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Polymorphisms of the NRAMP1 and hGPX1 genes may be associated with recurrence of BCa after BCG immunotherapy.
|
21163569 |
2011 |
Bladder Neoplasm
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The results indicate that polymorphism of GPX-1 gene influences the risk of developing bladder cancer in the Ecuadorian population, suggesting that more research on detoxifying genes in bladder cancer should be conducted.
|
20441054 |
2010 |
Bladder Neoplasm
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Se status, GPx1 Pro198Leu and Sep15 1125G/A genetic polymorphism and human (h)GPx1, hGPx3, hSep15 and hSeP1 transcript levels in peripheral leukocytes of 33 males with bladder cancer and 47 healthy male controls were analysed.
|
19728855 |
2009 |
Bladder Neoplasm
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Our findings suggest that a genetic polymorphism in the hGPX1 gene may serve as a molecular marker for monitoring bladder cancer recurrence.
|
16230136 |
2005 |
Bladder Neoplasm
|
0.400 |
Biomarker
|
disease |
CTD_human |
The GPX1 Pro/Leu genotype may significantly increase the risk of bladder cancer and the increased risk may be modified by the Ala-9Val MnSOD polymorphism.
|
15247771 |
2004 |
Bladder Neoplasm
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The GPX1 Pro/Leu genotype may significantly increase the risk of bladder cancer and the increased risk may be modified by the Ala-9Val MnSOD polymorphism.
|
15247771 |
2004 |
Bladder Neoplasm
|
0.400 |
GeneticVariation
|
disease |
LHGDN |
The GPX1 Pro/Leu genotype may significantly increase the risk of bladder cancer and the increased risk may be modified by the Ala-9Val MnSOD polymorphism.
|
15247771 |
2004 |